Get started
Author

Sudarshan Ramachandran

Observed names: Ramachandran Sudarshan, S Ramachandran, S. Ramachandran, Sud Ramachandran, Sudarshan, Ramachandran
Observed institutions: University Hospitals Birmingham NHS Foundation Trust, University of Bedfordshire, University of Staffordshire, Queen Elizabeth Hospital Birmingham, Good Hope Hospital, Heart of England NHS Foundation Trust, University Hospitals of North Midlands NHS Trust, Russells Hall Hospital, Royal Stoke University Hospital, University of Warwick, Heartlands Hospital, Walsall Manor Hospital, Keele University, Brunel University of London, Sheffield Hallam University, University of Birmingham
ORCID: 0000-0003-2299-4133
Observed ORCID: 0000-0003-2299-4133
OpenAlex ID: A5001987287
Glutathione-S-transferase family of enzymes
2001 · Richard C Strange, Monica A Spiteri, et al. · Mutation research. Fundamental and molecular mechanisms of mutagenesis · 831
Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis
2022 · Jemma Hudson, Moira Cruickshank, et al. · The Lancet Healthy Longevity · 109
PDF
The British Society for Sexual Medicine Guidelines on Male Adult Testosterone Deficiency, with Statements for Practice
2023 · Geoffrey Hackett, Michael Kirby, et al. · The World Journal of Men s Health · 93
PDF
Serum testosterone, testosterone replacement therapy and all-cause mortality in men with type 2 diabetes: retrospective consideration of the impact of PDE5 inhibitors and statins
2016 · G. Hackett, A. H. Heald, et al. · International Journal of Clinical Practice · 92
PDF
Associations between ultraviolet radiation, basal cell carcinoma site and histology, host characteristics, and rate of development of further tumors
2005 · Tracy J. Lovatt, John T. Lear, et al. · Journal of the American Academy of Dermatology · 81
Cutaneous basal cell carcinomas
2001 · Sudarshan Ramachandran, Anthony A. Fryer, et al. · Cancer · 71
Presentation with multiple cutaneous basal cell carcinomas: association of glutathione S-transferase and cytochrome P450 genotypes with clinical phenotype.
1999 · S Ramachandran, J T Lear, et al. · PubMed · 69
Serum testosterone levels in male hypogonadism: Why and when to check-A review
2017 · Mark Livingston, Anura Kalansooriya, et al. · International Journal of Clinical Practice · 67
PDF
Testosterone undecanoate improves sexual function in men with type 2 diabetes and severe hypogonadism: results from a 30‐week randomized placebo‐controlled study
2016 · Geoffrey Hackett, Nigel Cole, et al. · British Journal of Urology · 58
PDF
Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy
2009 · P. W.X. Foley, B. Stegemann, et al. · European Heart Journal · 52
PDF
Testosterone and the Heart
2019 · Michael Kirby, Geoffrey Hackett, et al. · European Cardiology Review · 51
Use of fibrates in the metabolic syndrome: A review
2016 · Kate E Shipman, Richard C Strange, et al. · World Journal of Diabetes · 51
PDF
Combined effects of gender, skin type and polymorphic genes on clinical phenotype: use of rate of increase in numbers of basal cell carcinomas as a model system
2002 · Sudarshan Ramachandran, Anthony A Fryer, et al. · Cancer Letters · 50
Statin, testosterone and phosphodiesterase 5-inhibitor treatments and age related mortality in diabetes
2017 · Geoffrey Hackett, Peter W Jones, et al. · World Journal of Diabetes · 47
PDF
Basal cell carcinomas: association of allelic variants with a high-risk subgroup of patients with the multiple presentation phenotype
2001 · Sudarshan Ramachandran, Anthony A. Fryer, et al. · Pharmacogenetics · 46
Long‐term testosterone therapy in type 2 diabetes is associated with reduced mortality without improvement in conventional cardiovascular risk factors
2018 · Geoffrey Hackett, Nigel Cole, et al. · British Journal of Urology · 43
Polymorphism in the nuclear excision repair geneERCC2/XPD: association between an exon 6-exon 10 haplotype and susceptibility to cutaneous basal cell carcinoma
2005 · Tracy Lovatt, Julie Alldersea, et al. · Human Mutation · 43
Basal cell carcinoma
2000 · Sudarshan Ramachandran, Anthony A. Fryer, et al. · Cancer · 42
PDF
Sex Hormone Binding Globulin: A Review of its Interactions With Testosterone and Age, and its Impact on Mortality in Men With Type 2 Diabetes
2019 · Sudarshan Ramachandran, Geoffrey I. Hackett, et al. · Sexual Medicine Reviews · 40
PDF
Glutathione S-transferase GSTP1 and cyclin D1 genotypes: association with numbers of basal cell carcinomas in a patient subgroup at high-risk of multiple tumours
2000 · Sudarshan Ramachandran, Paul R. Hoban, et al. · Pharmacogenetics · 40
Environment, phenotype and genetics: risk factors associated with BCC of the skin
2002 · Paul R Hoban, Sudarshan Ramachandran, et al. · Expert Review of Anticancer Therapy · 39
Symptomatic benefits of testosterone treatment in patient subgroups: a systematic review, individual participant data meta-analysis, and aggregate data meta-analysis
2023 · Jemma Hudson, Moira Cruickshank, et al. · The Lancet Healthy Longevity · 38
PDF
A comparison of sunlight exposure in men with prostate cancer and basal cell carcinoma
2007 · N J Rukin, M P Zeegers, et al. · British Journal of Cancer · 38
PDF
Measurement of Lamotrigine Under Conditions Measuring Phenobarbitone, Phenytoin, and Carbamazepine Using Reversed-Phase High-Performance Liquid Chromatography at Dual Wavelengths
1994 · Sudarshan Ramachandran, Stuart Underhill, et al. · Therapeutic Drug Monitoring · 37
Long-Term Testosterone Therapy in Type 2 Diabetes Is Associated with Decreasing Waist Circumference and Improving Erectile Function
2018 · Geoffrey Hackett, Nigel Cole, et al. · The World Journal of Men s Health · 30
Works count: 128
Citation count: 2,745
H-index: 26
I10-index: 49
Year
Topic
Type